Clinical Trial Update: Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose chidamide as maintenance therapy after allogeneic hematopoietic stem cell transplantation in T-cell acute lymphoblastic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphomas

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Zhejiang University | Conditions: T Lymphoblastic Leukemia/Lymphoma | Phase 2 | Status: COMPLETED